NCT02439203View on ClinicalTrials.gov

Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

January 31, 2016

Conditions
Parkinson's DiseaseLevodopa Induced Dyskinesia (LID)
Interventions
DRUG

JM-010

DRUG

Placebo

Trial Locations (1)

Unknown

Bloemfontein

Sponsors

Collaborators (1)

Contera Pharma ApS
All Listed Sponsors
collaborator

Contera Pharma ApS

UNKNOWN

lead

Bukwang Pharmaceutical

INDUSTRY

NCT02439203 - Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia | Biotech Hunter | Biotech Hunter